GlassScriptPhysician profile
Erica Brooke Eidson
NPI 1295276996
$18,548.74
in general payments reported to CMS, 2019-2025
56 companies · $2,394 in 2025
The $2,394 reported for 2025 was more than what 95% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,740 · 2022: $4,120 · 2023: $4,636 · 2024: $3,658 · 2025: $2,394.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Travel and Lodging: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,668.69 |
| Travel and Lodging | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,970.63 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Insulet Corporation | $1,608.88 | 2021-2025 | Omnipod |
| Corcept Therapeutics | $1,332.91 | 2021-2025 | Korlym |
| Xeris Pharmaceuticals, INC. | $1,303.30 | 2021-2025 | Recorlev, Gvoke Hypopen |
| Medtronic, INC. | $1,188.39 | 2021-2025 | Minimed 780g, Inpen Smart Insulin Delivery System, Minimed 770g |
| Lilly USA, LLC | $1,183.53 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Abbott Laboratories | $1,036.89 | 2021-2025 | Freestyle Libre 3 |
| Tandem Diabetes Care, INC. | $920.39 | 2021-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Amgen INC. | $905.13 | 2021-2024 | Repatha, Evenity, Prolia |
| Sanofi-Aventis U.S. LLC | $796.57 | 2021-2025 | |
| Beta Bionics, INC. | $732.49 | 2023-2024 | Ilet Bionic Pancreas |
| Novartis Pharmaceuticals Corporation | $663.57 | 2022-2025 | |
| Dexcom, INC. | $549.27 | 2021-2025 | Dexcom G6 Transmitter |
| Sequel Med Tech, LLC | $422.29 | 2025 | Twiist |
| Boehringer Ingelheim Pharmaceuticals, INC. | $382.11 | 2021-2024 | Jardiance, Synjardy, Tradjenta |
Show all 56 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erica Eidson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.